TOPICS: Imatinib, dasatinib, nilotinib, bcr abl tyrosine kinase, cml, all, c-kit tyrosine kinase, gi stromal tumors, gist, fluid retention, periorbital edema, ankle edema, erlotinib, egfr inhibitor, non small cell lung cancer, pancreatic cancer, xerosis, acneiform rash, diarrhea, dabrafenib, vemurafenib, braf oncogene, serine threonine kinase, metastatic melanoma, nausea, vomiting
